Amryt to delist from AIM and trade solely on Nasdaq Irish pharmaceutical company, Amryt, is to delist its shares from London's Alternative Investment Market (AIM) and trade solely on the Nasdaq Global Select Market. Business • 22 Nov 21
Glantus starts trading on London's AIM Irish company Glantus, which provides accounts payable automation and analytics solutions, has today announced its flotation and admission to the AIM market of London Stock … Business • 11 May 21
Open Orphan raises £12m for Covid-19 testing Irish pharmaceutical firm Open Orphan has raised £12m, which it will put towards the hunt to find a vaccine for Covid-19. Business • 22 May 20
Diaceutics starts trading on London's AIM today Diaceutics, the diagnostics data analytics and implementation services company, has started trading on London's AIM market today with a market capitalisation of £52.9m. Business • 21 Mar 19
Yew Grove REIT raises €75m ahead of IPO Yew Grove REIT, a new Irish Real Estate Investment Trust managed by its executive directors, has successfully raised gross proceeds of about €75m. Business • 05 Jun 18
Dalata to move from AIM and ESM to main markets Dalata Hotel Group has said it intends to move its listings from the ESM market of the Irish Stock Exchange to trading on the primary … Business • 02 Jun 16
GameAccount Network places £22m in shares GameAccount Network, the gaming software firm headed by Dermot Smurfit Junior, has raised £22.2m in the successful placing of new shares. Business • 20 Nov 13
Rangers plans to float shares on AIM Rangers has announced plans to raise £20m sterling by floating some of its shares on the London stock exchange. Business • 11 Oct 12
Petroceltic shares back on ESM and AIM markets The shares of exploration company Petroceltic have been readmitted to the ESM market of the Irish Stock Exchange and the AIM market on the London … Business • 11 Oct 12
